» Articles » PMID: 28697916

Treatments for Opioid Use Disorder Among Pregnant and Reproductive-aged Women

Overview
Journal Fertil Steril
Date 2017 Jul 13
PMID 28697916
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The increased prevalence of opioid use disorder and access to medical insurance is subsequently increasing the likelihood that medical professionals will encounter individuals with opioid use disorder. Sharp increases in opioid use disorder among women mean that obstetricians, gynecologists, and other reproductive medicine providers may be especially likely to encounter such patients. Medical professionals' understanding of treatment for opioid use disorder and their roles in their patients' treatment may increase referrals to treatment, reduce stigma, and improve the quality of medical care. Treatment for opioid use disorder falls into four overlapping domains: medication management, medical care, behavioral/mental health care, and psychosocial support. In this review, we discuss these domains with an emphasis on pregnant women and women of reproductive age. Treatment for opioid use disorder is most effective when all providers coordinate care in an informed, nonjudgmental, patient-centered approach.

Citing Articles

Promoting Innovation in State and Territorial Maternal and Child Health Policymaking.

Akbarali S, Dronamraju R, Simon J, Echols A, Collins S, Kaeberle B Matern Child Health J. 2023; 27(Suppl 1):5-13.

PMID: 37792151 PMC: 10692248. DOI: 10.1007/s10995-023-03779-1.


Health Status and Preventive Health Services Among Reproductive-Aged Women in Treatment for Opioid Use Disorder.

Short V, Hand D, Pyfer L, Steiger H, Gannon M, Jaffe G Womens Health Rep (New Rochelle). 2023; 3(1):998-1005.

PMID: 36636314 PMC: 9811839. DOI: 10.1089/whr.2022.0057.


A Scoping Review of Computer-Based and Telecommunication Technology Interventions to Address Drug and Alcohol Misuse and Smoking in Women.

Washio Y, Hayashi Y, Atreyapurapu S, Chang K, Ma T, Howard B Subst Use Misuse. 2022; 57(8):1257-1272.

PMID: 35582861 PMC: 10083725. DOI: 10.1080/10826084.2022.2076878.


Saving time, signaling trust: Using the PROMOTE self-report screening instrument to enhance prenatal care quality and therapeutic relationships.

Preis H, Whitney C, Kocis C, Lobel M PEC Innov. 2022; 1.

PMID: 35465253 PMC: 9020232. DOI: 10.1016/j.pecinn.2022.100030.


Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics.

Forray A, Mele A, Byatt N, Tobon A, Gilstad-Hayden K, Hunkle K PLoS One. 2022; 17(1):e0261751.

PMID: 35025898 PMC: 8758001. DOI: 10.1371/journal.pone.0261751.